Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Teng Long
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0000-0002-2781-3808
Observed ORCID:
0000-0002-2781-3808
OpenAlex ID:
A5103236331
Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
2023
·
Teng Long
, Zhoutian Yang
, et al.
·
Journal of Hepatocellular Carcinoma
·
11
PDF
The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab
2024
·
Weijie Wu
, Zhenyun Yang
, et al.
·
Frontiers in Immunology
·
5
PDF
Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD
2025
·
Teng Long
, Zhenyun Yang
, et al.
·
iLiver
·
2
PDF
Proposing re-classification of bile duct cancer and intrahepatic cholangiocarcinoma: A suggested modification based on the WHO classification
2025
·
Yangxun Pan
, Dandan Hu
, et al.
·
European Journal of Surgical Oncology
·
1
Show more works
View as search
Works count:
4
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type